ENHO and metabolic dysfunction-associated steatohepatitis: Using real-time qRT-PCR assay, we further validated that both adropin and Colgalt2 were significantly upregulated in the liver (Supplemental Figure 6), correlating with the reduction in steatosis and amelioration of NASH in MøFoxO1-KO mice.